comparemela.com

Latest Breaking News On - Anticoagulation - Page 9 : comparemela.com

LAAO Tied to Fewer Post-Fall Bleeds Than DOACs in AF

Cognitive Problems Transient After AF Ablation

Anticoagulants for Cancer-Related VTE: What Works Best?

Cancer patients with venous thromboembolism should preferentially be given direct oral anticoagulants over other drugs to reduce the risk of major complications, a recent analysis shows.

Routine Thromboprophylaxis for Advanced Ovarian Cancer?

Two thirds of venous thromboembolism events came during neoadjuvant chemotherapy and might have been prevented with direct-acting oral anticoagulants, a new study suggests.

Indefinite anticoagulation for unprovoked venous thromboembolism is not cost-effective

1. In this Markov modeling study, indefinite anticoagulation for first unprovoked venous thromboembolism (VTE) cost $16,014 more per person than discontinuation based on clinical guidelines. 2. Indefinite anticoagulation for first unprovoked VTE did not increase the number of quality-adjusted life-years (QALYs) per patient. Evidence Rating Level: 1 (Excellent) Study Rundown: VTE is estimated to have a

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.